JPH05255045A - Hair grower - Google Patents
Hair growerInfo
- Publication number
- JPH05255045A JPH05255045A JP4089807A JP8980792A JPH05255045A JP H05255045 A JPH05255045 A JP H05255045A JP 4089807 A JP4089807 A JP 4089807A JP 8980792 A JP8980792 A JP 8980792A JP H05255045 A JPH05255045 A JP H05255045A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- molecular weight
- extract
- salts
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004209 hair Anatomy 0.000 title claims abstract description 39
- 239000000284 extract Substances 0.000 claims abstract description 25
- 229920002683 Glycosaminoglycan Polymers 0.000 claims abstract description 20
- 230000002378 acidificating effect Effects 0.000 claims abstract description 19
- 150000003839 salts Chemical class 0.000 claims abstract description 17
- 239000010396 fuzi Substances 0.000 claims description 9
- 230000000694 effects Effects 0.000 abstract description 20
- 208000001840 Dandruff Diseases 0.000 abstract description 9
- 230000002265 prevention Effects 0.000 abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 230000003779 hair growth Effects 0.000 description 22
- 239000002904 solvent Substances 0.000 description 17
- 239000003795 chemical substances by application Substances 0.000 description 15
- 230000001737 promoting effect Effects 0.000 description 11
- -1 alkali metal salts Chemical class 0.000 description 10
- 238000012360 testing method Methods 0.000 description 10
- 229920002567 Chondroitin Polymers 0.000 description 9
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 9
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 8
- 229920002674 hyaluronan Polymers 0.000 description 8
- 229960003160 hyaluronic acid Drugs 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 241000227129 Aconitum Species 0.000 description 6
- 201000004384 Alopecia Diseases 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 238000010438 heat treatment Methods 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 229920002971 Heparan sulfate Polymers 0.000 description 5
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 5
- 230000003658 preventing hair loss Effects 0.000 description 5
- 238000010998 test method Methods 0.000 description 5
- 229920001287 Chondroitin sulfate Polymers 0.000 description 4
- 229920000045 Dermatan sulfate Polymers 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 229940051593 dermatan sulfate Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 241000173529 Aconitum napellus Species 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000027294 Fusi Species 0.000 description 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000003676 hair loss Effects 0.000 description 3
- 208000024963 hair loss Diseases 0.000 description 3
- 229960002897 heparin Drugs 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KIUKXJAPPMFGSW-YXBJCWEESA-N (2s,4s,5r,6s)-6-[(2s,3r,5s,6r)-3-acetamido-2-[(3s,4r,5r,6r)-6-[(3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@@H]3[C@@H]([C@@H](O)C(O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)C(C(O)=O)O1 KIUKXJAPPMFGSW-YXBJCWEESA-N 0.000 description 2
- 241000254173 Coleoptera Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 125000002059 L-arginyl group Chemical class O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229940023019 aconite Drugs 0.000 description 2
- 150000002952 aconitine derivatives Chemical class 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 206010068168 androgenetic alopecia Diseases 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229940094517 chondroitin 4-sulfate Drugs 0.000 description 2
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 210000003128 head Anatomy 0.000 description 2
- 229920000669 heparin Polymers 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 230000003405 preventing effect Effects 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- 241000553759 Aconitum coreanum Species 0.000 description 1
- 241000701413 Aconitum kusnezoffii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N Butanol Natural products CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- 238000011735 C3H mouse Methods 0.000 description 1
- 208000019300 CLIPPERS Diseases 0.000 description 1
- 240000001980 Cucurbita pepo Species 0.000 description 1
- 235000009852 Cucurbita pepo Nutrition 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 235000019766 L-Lysine Nutrition 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000238413 Octopus Species 0.000 description 1
- 235000006089 Phaseolus angularis Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000218201 Ranunculaceae Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000010711 Vigna angularis Nutrition 0.000 description 1
- 240000007098 Vigna angularis Species 0.000 description 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 201000002996 androgenic alopecia Diseases 0.000 description 1
- 230000002280 anti-androgenic effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000000051 antiandrogen Substances 0.000 description 1
- 229940030495 antiandrogen sex hormone and modulator of the genital system Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000000637 arginyl group Chemical class N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 208000021930 chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids Diseases 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000012364 cultivation method Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000003808 decrease of hair loss Effects 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 231100000640 hair analysis Toxicity 0.000 description 1
- 230000003662 hair growth rate Effects 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 125000000487 histidyl group Chemical class [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000003055 low molecular weight heparin Substances 0.000 description 1
- 229940127215 low-molecular weight heparin Drugs 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、育毛効果及び養毛効
果、脱毛予防、ふけ防止等の効果に優れた養毛料に関す
る。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a hair nourishing agent which is excellent in hair growth effect, hair nourishing effect, hair loss prevention, dandruff prevention and the like.
【0002】[0002]
【従来技術】脱毛症は様々な要因が複雑に絡みあって生
じていると考えられており、発生機作が未だ充分に解明
されていないのが現状である。従来より、各種の薬剤を
配合した養毛料が脱毛の予防や治療に用いられてきてい
るが、脱毛を抑制して発毛、養毛を促すに充分有効な薬
剤は未だ見出されていない。2. Description of the Related Art Alopecia is considered to be caused by various factors intricately intertwined with each other, and the mechanism of occurrence is still unclear. Conventionally, a hair nourishing agent containing various agents has been used for the prevention and treatment of hair loss, but a drug effective enough to suppress hair loss and promote hair growth and hair nourishment has not yet been found.
【0003】本発明の養毛料の原料に用いる附子は、古
来中国において神農本草経に記載され、漢方医学上種々
の漢方処方中に汎用される重要な生薬として知られるも
ので、キンポウゲ科(Ranunculaceae)の
トリカブト属植物(Aconitum specie
s)の塊根から調製される。特開平3−271213号
に、この基源植物であるトリカブトの根、茎又は葉の抽
出物を含有することを特徴とした発毛・育毛剤が提案さ
れているが、トリカブトの抽出物単独使用であり、発
毛、育毛効果は不充分であった。[0003] The fusi, which is used as a raw material for the hair nourishing agent of the present invention, has been described in China since ancient times as a herbal sutra and is known as an important crude drug that is widely used in various Kampo prescriptions in Kampo medicine. ) Aconitum species (Aconitum specie)
s) tuberous root. Japanese Patent Laid-Open No. 3-271213 proposes a hair growth and hair-growing agent characterized by containing an extract of the root, stem or leaf of aconite, which is the source plant, but the extract of aconite alone is used. The hair growth and hair growth effects were insufficient.
【0004】[0004]
【発明が解決しようとする課題】本発明者は、上記事情
に鑑み、鋭意研究を重ねた結果、低分子量酸性ムコ多糖
類及びその塩類の群より選択された少なくとも一種と附
子の抽出物とを配合することによって、安全性が高く、
マウス毛成長促進、ヒト頭髪毛成長促進に優れた効果を
示し、更に、ふけ防止効果にも著効を呈することを見出
して本発明を完成するに至った。即ち、本発明の目的
は、育毛、養毛、脱毛予防、ふけ防止等の効果に優れた
養毛料を提供することにある。DISCLOSURE OF THE INVENTION In view of the above circumstances, the present inventor has conducted extensive studies and as a result has found that at least one selected from the group of low molecular weight acidic mucopolysaccharides and salts thereof and an extract of aconidium. By blending, the safety is high,
The present inventors have completed the present invention by finding that they show excellent effects in promoting mouse hair growth and human hair growth, and exhibit a remarkable effect in preventing dandruff. That is, an object of the present invention is to provide a hair nourishing agent having excellent effects such as hair growth, hair nourishment, hair loss prevention, and dandruff prevention.
【0005】[0005]
【課題を解決するための手段】本発明は、低分子量の酸
性ムコ多糖類及びその塩類の群より選択された少なくと
も一種と附子の抽出物とを配合してなる養毛料である。The present invention is a hair nourishing agent containing at least one selected from the group of low-molecular-weight acidic mucopolysaccharides and salts thereof, and an extract of fusi.
【0006】本発明の養毛料に用いる酸性ムコ多糖類と
しては、ヒアルロン酸、デルマタン硫酸、コンドロイチ
ン4硫酸、コンドロイチン6硫酸、ヘパリン、ヘパラン
硫酸等が使用可能であり、それらはいずれも公知の物質
であって、軟骨、関節、眼球、皮膚その他の結合組織に
基質成分となって、蛋白質と結合した状態で動物体内に
広く分布している。As the acidic mucopolysaccharide used in the hair nourishing agent of the present invention, hyaluronic acid, dermatan sulfate, chondroitin 4-sulfate, chondroitin 6-sulfate, heparin, heparan sulfate and the like can be used, and all of them are known substances. Therefore, it is widely distributed in the animal body as a matrix component in cartilage, joints, eyeballs, skin and other connective tissues and bound to proteins.
【0007】また、本発明に用いる低分子量の酸性ムコ
多糖類は、天然品を更に低分子化したもので、その分子
量は、ヒアルロン酸が1,000〜100,000未
満、デルマタン硫酸、コンドロイチン4硫酸、コンドロ
イチン6硫酸が1,000〜10,000未満、ヘパリ
ン、ヘパラン硫酸が1,000〜7,000未満のもの
が好適である。The low-molecular-weight acidic mucopolysaccharide used in the present invention is a product obtained by further reducing the molecular weight of natural products. The molecular weight of hyaluronic acid is 1,000 to less than 100,000, dermatan sulfate, chondroitin 4 Sulfuric acid and chondroitin 6-sulfate are preferably 1,000 to less than 10,000, and heparin and heparan sulfate are preferably 1,000 to less than 7,000.
【0008】本発明に用いる酸性ムコ多糖類の塩として
は、前記ムコ多糖類のナトリウム塩、カリウム塩などの
アルカリ金属塩、マグネシウム塩、カルシウム塩などの
アルカリ土類金属塩、アンモニウム塩、トリエタノール
アミン塩などのアルカノールアミン塩、リジン塩、アル
ギニン塩、ヒスチジン塩などの塩基性アミノ酸塩が好ま
しいものとして挙げられる。また、これらの酸性ムコ多
糖類は遊離状の酸としても使用できる。The salt of the acidic mucopolysaccharide used in the present invention includes alkali metal salts such as sodium and potassium salts of the mucopolysaccharide, alkaline earth metal salts such as magnesium salt and calcium salt, ammonium salt and triethanol. Alkanolamine salts such as amine salts, basic amino acid salts such as lysine salts, arginine salts and histidine salts are preferred. Further, these acidic mucopolysaccharides can also be used as a free acid.
【0009】本発明に用いる酸性ムコ多糖類及びその塩
は、下記の如くに得ることができる。 (1)低分子量
ヒアルロン酸及びその塩 平均分子量が100万の市販されているヒアルロン酸5
gを、100mlの0.02Nの塩酸水溶液に分散溶解
し、pH2〜3に調製し攪拌しながら温浴中で65℃に
加温する。この加温処理時間を各々10分から120分
に変えることにより、平均分子量が1,000から10
0,000のヒアルロン酸をえることができる。 次い
で、0.1N水酸化ナトリウムで中和した後、該溶液を
室温まで冷却し、エタノール3倍容を加えて得られる沈
殿物を乾燥して低分子量ヒアルロン酸ナトリウム塩の粉
末を得た。また、この低分子量ヒアルロン酸ナトリウム
塩を酸で処理して遊離のヒアルロン酸とし、次に他の塩
基性物質で処理して、例えば、カリウム塩、トリエタノ
ール塩、L−アルギニン塩等の塩類を調製した。The acidic mucopolysaccharides and salts thereof used in the present invention can be obtained as follows. (1) Low molecular weight hyaluronic acid and its salt Commercially available hyaluronic acid having an average molecular weight of 1,000,000 5
g is dispersed and dissolved in 100 ml of 0.02 N hydrochloric acid aqueous solution, adjusted to pH 2-3, and heated to 65 ° C. in a warm bath while stirring. By changing the heating treatment time from 10 minutes to 120 minutes, the average molecular weight was changed from 1,000 to 10 minutes.
It is possible to obtain 10,000 hyaluronic acid. Then, after neutralizing with 0.1N sodium hydroxide, the solution was cooled to room temperature, and 3 times volume of ethanol was added to obtain a precipitate, which was then dried to obtain low-molecular weight hyaluronic acid sodium salt powder. In addition, this low molecular weight hyaluronic acid sodium salt is treated with an acid to give free hyaluronic acid, and then treated with another basic substance, for example, salts such as potassium salt, triethanol salt, L-arginine salt, etc. Prepared.
【0010】(2)低分子量コンドロイチン4硫酸及び
その塩等 平均分子量が3万の市販されているコンドロイチン4硫
酸ナトリウム5gを50mlの水に溶かし、アンバーラ
イトIR−120(H型)のレジンカラムに通して得ら
れる流出液を攪拌しながら温浴中で75℃に加温する。
この加温処理時間を各々10分から120分に変えるこ
とにより、平均分子量が1,000から10,000の
コンドロイチン4硫酸をえることができる。次いで、
0.1N水酸化ナトリウムで中和した後、該溶液を室温
まで冷却し、エタノール3倍容を加えて得られる沈殿物
を遠心分離し、エタノールで洗浄した後、乾燥して低分
子量コンドロイチン4硫酸ナトリウム塩の粉末を得た。
更に、この低分子量コンドロイチン4硫酸ナトリウム塩
を酸で処理して遊離酸とし、他の塩基性物質で処理し
て、例えば、カリウム塩、トリエタノール塩、L−アル
ギニン塩等の塩類を調製した。(2) Low molecular weight chondroitin tetrasulfate and its salt, etc. 5 g of commercially available sodium chondroitin tetrasulfate having an average molecular weight of 30,000 was dissolved in 50 ml of water and applied to an Amberlite IR-120 (H type) resin column. The effluent obtained through is warmed to 75 ° C. in a warm bath with stirring.
By changing the heating treatment time from 10 minutes to 120 minutes, chondroitin tetrasulfate having an average molecular weight of 1,000 to 10,000 can be obtained. Then
After neutralizing with 0.1 N sodium hydroxide, the solution was cooled to room temperature, and a precipitate obtained by adding 3 volumes of ethanol was centrifuged, washed with ethanol, and then dried to give low molecular weight chondroitin tetrasulfate. A powder of sodium salt was obtained.
Further, this low molecular weight chondroitin tetrasulfate sodium salt was treated with an acid to give a free acid, and then treated with another basic substance to prepare salts such as potassium salt, triethanol salt and L-arginine salt.
【0011】また、低分子量コンドロイチン6硫酸、低
分子量デルマタン硫酸、低分子量ヘパリン、低分子量ヘ
パラン硫酸等についても、上記コンドロイチン4硫酸の
例と同様にして、遊離状あるいはそれぞれの塩類を調製
した。尚、各処理時間により得られた酸性ムコ多糖類の
平均分子量の測定方法は、ソモギー−ネルソン(Som
ogyi−Nelson)法を用いた。Further, low-molecular-weight chondroitin 6-sulfate, low-molecular-weight dermatan sulfate, low-molecular-weight heparin, low-molecular-weight heparan sulfate and the like were prepared in the free form or their respective salts in the same manner as in the above example of chondroitin 4-sulfate. In addition, the measuring method of the average molecular weight of the acidic mucopolysaccharide obtained by each treatment time is as follows.
Ogyi-Nelson) method was used.
【0012】一方、本発明の養毛料に用いる原料生薬の
附子は、キンポウゲ科(Ranunculaceae)
のトリカブト属植物(Aconitum specie
s)の塊根から調製されたものであればよく、その基源
及び産地を限定するものではない。また、一般に、トリ
カブト属植物には猛毒性アコニチン系アルカロイドを含
有しており、その使用に際しては細心の注意を要するも
のであるため、より好ましくは加熱処理等の減毒調製さ
れた加工附子と称されるものを用いるのがよい。[0012] On the other hand, the auxiliary of the raw herbal medicine used for the hair nourishing agent of the present invention is Ranunculaceae.
Aconitum plant (Aconitum specie)
As long as it is prepared from the tuberous root of s), its source and place of origin are not limited. Further, in general, aconite plants contain a highly toxic aconitine alkaloids, and since careful attention is required when using the aconitine alkaloids, more preferably, it is referred to as a processed aconitant prepared by detoxification such as heat treatment. It is better to use the one that is used.
【0013】附子の基源植物としては、例えば、中国四
州省産の栽培種カラトリカブト(Aconitum c
armichaeli Debx)、中国各地の野性種
(Aconitum kusnezoffii Rei
chb.)など、朝鮮産のミツバトリカブト(Acon
itum triphyllum Nakai)、キバ
ナトリカブト(Aconitum coreanum
Rap.)、日本産のオクトリカブト(Aconitu
m japonicum Thunb.)、ハナトリカ
ブト(Aconitum chinense Pax
t.)などが挙げられる。特に中国四州省産のカラトリ
カブトが、一定の栽培法で、品質の安定性および供給の
面で好ましい。[0013] Examples of the source plant of Fuzi are, for example, the cultivar Aconitum c.
armichaeli Debx), a wild species (Aconitum kusnezoffii Rei) from all over China.
chb. ), Etc. from Korea.
itum triphyllum Nakai), Aconitum coreanum
Rap. ), Japanese octopus beetle (Aconitu)
m japonicum Thunb. ), Aconitum chinese Pax
t. ) And the like. Particularly, the agar beetle produced in Sichuan Province of China is preferable in terms of quality stability and supply with a certain cultivation method.
【0014】また、減毒加工法としては、特許公告昭3
7−18498号に提案されている、塊根をオートクレ
ーブ中で100〜130℃、圧力1.0〜1.5kg/
cm2 20〜40分間加圧、加熱処理して調製する方法
が、簡便で、有効かつ安全な生薬を安定に生産できるこ
とから特に好ましい方法である。この方法で調製された
例として、日本薬局方外規品の商品名「加工ブシ末」が
挙げられる。また主に中国で行われている方法として、
水洗した塊根を苦汁液に数日間浸漬して乾燥するか、あ
るいは、更に蒸す、煮沸などの処理をくり返した後乾燥
して調製する方法または塊根を水洗し縦割りして鮮時に
灰中に埋没させ、加熱、加圧等を施し乾燥して調製する
方法などがある。この方法で調製した例としては中国四
州省産の附子瓣(日本では炮附子と称する)として市販
されているものが一定の品質で充分減毒されており好ま
しい。As the detoxification processing method, Japanese Patent Publication No. 3
No. 7-18498, the tuber root is 100-130 degreeC in an autoclave, and the pressure is 1.0-1.5 kg /.
The method of preparing by applying pressure and heat treatment for 20 to 40 minutes per cm 2 is a particularly preferable method because a crude drug can be stably produced in a simple, effective and safe manner. An example of the product prepared by this method is "Processed bush powder", which is a brand name product of the Japanese Pharmacopoeia. Also, as a method mainly used in China,
Soak the water-washed tuberous root in bitter juice for several days to dry it, or repeat the treatment such as steaming and boiling and then dry it, or wash the tuber with water and split it vertically and bury it in ash when fresh. Then, heating, pressurizing, etc. are applied and dried to prepare. As an example prepared by this method, a commercially available product of Fuzi gourd produced in Sichuan Province of China (referred to as Fuzi Fuzi in Japan) is preferable because it is sufficiently detoxified with a certain quality.
【0015】本発明の附子の抽出物は、附子を溶剤で抽
出した場合に附子から溶剤に移行し、た成分を言い、こ
の抽出物は溶剤を除去した後の乾燥物の状態で使用する
こともでき、また溶剤に溶解した状態で使用することも
できる。後者の場合には抽出溶剤は本発明の養毛料中で
基剤の一部を構成する。The extract of the adzuki bean of the present invention refers to a component which is transferred from the adsorbent to the solvent when the adsorbent is extracted with a solvent, and the extract is used in a dry state after removing the solvent. It can also be used in the state of being dissolved in a solvent. In the latter case, the extraction solvent will form part of the base in the hair restorer of the invention.
【0016】溶剤としては水、アルコール類、例えばメ
タノール、エタノール、ブタノールエーテル類、例えば
ジエチルエーテル、ジオキサン、ケトン類、例えばアセ
トン脂肪族炭化水素類、例えばペンタン、ヘキサン、シ
クロヘキサン、エステル類、例えば酢酸エチル等を使用
することができる。抽出物を溶剤除去して乾燥物として
使用する場合には、上記の任意の溶剤を単独でまたは混
合して使用することができる。しかしながら抽出物を溶
剤に溶解した状態で使用する場合には人体に有害な作用
を有しない水、エタノール、またはこれらの混合物を用
いるのが好ましい。Solvents include water, alcohols such as methanol, ethanol, butanol ethers such as diethyl ether, dioxane, ketones such as acetone aliphatic hydrocarbons such as pentane, hexane, cyclohexane, esters such as ethyl acetate. Etc. can be used. When the extract is removed by solvent and used as a dried product, any of the above-mentioned solvents can be used alone or in combination. However, when the extract is used in a state of being dissolved in a solvent, it is preferable to use water, ethanol, or a mixture thereof, which has no harmful effect on the human body.
【0017】抽出に際して、附子はそのまま使用するこ
ともでき、また破砕または粉砕して使用し、溶剤との接
触を改良することもできる。附子と溶剤との比率は特に
限定されないが、抽出効率及び便利さの観点から附子1
00g当たり100〜5000mlの溶剤を使用するの
が好ましい。抽出温度は室温〜常圧下での溶剤の沸点の
範囲とするのが便利であり、抽出時間は抽出温度、攪拌
の有無等により異なるが、30分〜2週間の範囲とする
のが好ましい。In the extraction, the adjunct may be used as it is, or may be crushed or crushed to improve the contact with the solvent. Although the ratio of the adjunct to the solvent is not particularly limited, the adjunct 1 is taken into consideration from the viewpoint of extraction efficiency and convenience.
Preference is given to using 100 to 5000 ml of solvent per 00 g. The extraction temperature is conveniently in the range of room temperature to the boiling point of the solvent under normal pressure, and the extraction time is preferably in the range of 30 minutes to 2 weeks, although it varies depending on the extraction temperature, the presence or absence of stirring and the like.
【0018】本発明者は、養毛料中に配合する上記構成
成分に関して鋭意研究した結果、本発明の附子の抽出物
と、低分子量の酸性ムコ多糖類及びその塩類とを配合し
た養毛料は、その相乗作用によって優れた育毛効果(マ
ウス毛成長促進効果、ヒト頭髪毛成長促進効果)、養毛
効果、脱毛予防、ふけ防止効果などの効果を有すること
を見出した。The present inventor has conducted extensive studies on the above-mentioned constituents to be incorporated in the hair nourishment, and as a result, the hair nourishing agent containing the extract of Fushi of the present invention and the low-molecular-weight acidic mucopolysaccharide and salts thereof has It was found that the synergistic effects have excellent hair growth effects (mouse hair growth promoting effect, human hair growth promoting effect), hair nourishing effect, hair loss prevention, dandruff prevention effect, and the like.
【0019】本発明の附子の抽出物と低分子量の酸性ム
コ多糖類及びその塩類の配合割合は、当該養毛料の剤型
などにより適宜選択されるものであるが、養毛料の総量
を基準として、附子の抽出物は、0.0001〜20.
0wt%(乾燥物換算)、低分子量酸性ムコ多糖類及び
その塩類は、0.01〜3.0wt%であればよく、各
々の配合量の下限未満では、本発明の目的とする効果に
充分でなく、一方、上限を超えてもその増加分に見合っ
た効果の向上は望めないものである。The blending ratio of the extract of Fuzi of the present invention and the low-molecular-weight acidic mucopolysaccharide and its salts is appropriately selected depending on the dosage form of the hair restorer, etc., but based on the total amount of the hair restorer. , The extract of Fuzi is 0.0001-20.
0 wt% (dry matter conversion), low molecular weight acidic mucopolysaccharides and salts thereof may be 0.01 to 3.0 wt%, and if the amount is less than the lower limit of each, sufficient effect for the purpose of the present invention is obtained. On the other hand, even if the upper limit is exceeded, improvement in the effect commensurate with the increase cannot be expected.
【0020】本発明の養毛料は、常法に従って、ヘアー
トニック、ヘアーローション、ヘアークリーム、シャン
プー、リンス、ヘアーフォーム、ヘアージェル等の剤型
にすることが可能である。The hair nourishing agent of the present invention can be made into a dosage form such as a hair tonic, a hair lotion, a hair cream, a shampoo, a rinse, a hair foam and a hair gel according to a conventional method.
【0021】本発明の養毛料には、色素、香料、殺菌
剤、防腐剤、角質溶解剤、消炎剤、抗アンドロゲン剤、
養毛剤、ビタミン類、抗酸化剤、清涼剤、他の生薬抽出
物等を本発明の目的を達成する範囲内で適宜配合するこ
とができる。The hair nourishing agent of the present invention includes pigments, fragrances, germicides, preservatives, keratolytic agents, anti-inflammatory agents, anti-androgens,
Hair nourishing agents, vitamins, antioxidants, cooling agents, extracts of other herbal medicines and the like can be appropriately added within the range that achieves the object of the present invention.
【0022】[0022]
【実施例】以下、実施例および比較例に基づいて本発明
を詳説する。なお、実施例に記載のマウス毛成長促進効
果試験法、ヒト頭髪毛成長促進効果試験法および実用試
験法を下記に示す。EXAMPLES The present invention will be described in detail below based on examples and comparative examples. The mouse hair growth promoting effect test method, human hair growth promoting effect test method and practical test method described in Examples are shown below.
【0023】(1)マウス毛成長促進効果試験 C3Hマウス(雄・7週齢)の背部中央の体毛をバリカ
ン及びシェーバー等で毛刈し、試料を毛刈り部位に1日
1回、一匹当り0.2ml塗布した。一試料に対して動
物は一群10匹使用した。実験開始後15日目にマウス
背部の写真撮影を行い、毛刈り面積及び発毛面積を算出
し、発毛率(%)を求め10例の平均値により、毛成長
促進効果を判定した。(1) Mouse Hair Growth Promoting Effect Test C3H mice (male, 7 weeks old) were shaved with a hair clipper and a shaver on the central back hair of each mouse, and the sample was cut at the shaved site once a day per animal. 0.2 ml was applied. For each sample, 10 animals were used per group. On the fifteenth day after the start of the experiment, the back of the mouse was photographed, the hair cutting area and the hair growth area were calculated, the hair growth rate (%) was calculated, and the hair growth promoting effect was determined by the average value of 10 cases.
【0024】(2)ヒト頭髪毛成長促進効果試験法 男性型脱毛症患者である被試験者10名の頭部の耳の上
5cmの位置の頭髪を左右2カ所において直径1cmの
円型状に剃毛した被験部位に、実施例または比較例の試
料を左側に毎日朝夕2回、約3ml塗布し、無処置の右
側と比較した。効果の判定は、試験開始後28日目に、
左右の被験部位の毛髪各々20本ずつを剃毛し、左側
(実施例または比較例を塗布)の毛20本の長さの平均
値(B)を右側(無処置)の毛20本の長さの平均値
(A)で除した値を求めて評価した。判定結果は、被試
験者10名の(B)/(A)の平均値で示した。(2) Human hair growth promoting effect test method 10 hair test subjects who are male pattern baldness have circular hair with a diameter of 1 cm at 5 cm above the ears of the head. About 3 ml of the sample of Example or Comparative Example was applied to the left side of the shaved test site twice daily in the morning and evening, and compared with the untreated right side. Evaluation of the effect is 28 days after the start of the test,
20 hairs on each of the left and right test sites are shaved, and the average value (B) of the lengths of 20 hairs on the left side (applied Example or Comparative Example) is calculated as the length of 20 hairs on the right side (untreated). The value obtained by dividing the average value (A) of the sacks was obtained and evaluated. The determination result was shown by the average value of (B) / (A) of 10 test subjects.
【0025】(3)実用試験法 男性型脱毛症患者である被試験者20名の頭部に毎日朝
夕2回、連続6カ月間試料を塗布した後の効果を評価し
た。試験結果は、育毛効果、脱毛予防効果、ふけ防止効
果の各項目に対して、「生毛が剛毛化したあるいは生毛
が増加した」、「脱毛が少なくなった」、「ふけが少な
くなった」と回答した人数で示した。(3) Practical test method 20 heads of androgenetic alopecia patients were applied with the sample twice daily in the morning and evening and continuously for 6 months to evaluate the effect. The test results were "hair bristling or increased hair loss", "less hair loss", "less dandruff" for each item of hair growth effect, hair loss prevention effect, and dandruff prevention effect. The number of people who answered
【0026】製造例1(附子の抽出物の調製) (1)中国四州省産附子(川烏頭、または干附子として
市販のもの)の乾燥塊根の破砕物をオートクレーブ中で
100〜130℃、圧力1〜1.5kg/cm2 に調製
し、40分間加圧、加熱処理する。加工処理した附子1
00gを1500mlの70v/v%エタノール(以
降、v/v%を%に略記する)に、常温(20〜25
℃)にて16時間浸し、上澄液をろ取して、45℃、減
圧下にて3時間濃縮し、溶媒を溜去して、褐色の抽出物
を11.7g得た。Production Example 1 (Preparation of extract of Fuzi) (1) A crushed product of dried root of Fuzi produced in Sichuan Province of China (commercially available as river crow or dried zizi) in an autoclave at 100 to 130 ° C. The pressure is adjusted to 1 to 1.5 kg / cm 2 , and pressure and heat treatment are performed for 40 minutes. Azushi 1 processed
00 g to 1500 ml of 70 v / v% ethanol (hereinafter, v / v% is abbreviated to%) at room temperature (20 to 25%).
C.) for 16 hours, the supernatant was collected by filtration, concentrated under reduced pressure at 45.degree. C. for 3 hours, and the solvent was distilled off to obtain 11.7 g of a brown extract.
【0027】(2)製造例1(1)と同様に加工処理し
た中国四州省産附子100gを1500mlの40%エ
タノールに、常温(20〜25℃)にて16時間浸し、
上澄液をろ取して45℃、減圧下にて4時間濃縮し、溶
媒を溜去して、褐色の抽出液を13.4g得た。(2) Preparation Example 1 100 g of Zhifu Province from China which was processed in the same manner as in (1) was immersed in 1500 ml of 40% ethanol for 16 hours at room temperature (20 to 25 ° C.),
The supernatant was collected by filtration and concentrated under reduced pressure at 45 ° C. for 4 hours, and the solvent was distilled off to obtain 13.4 g of a brown extract.
【0028】(3)中国四州省産の炮附子(附子瓣とし
て市販のもの)を50gを500mlの70%エタノー
ルに、常温(20〜25℃)にて16時間浸し、上澄液
をろ取し、45℃で減圧下にて2時間濃縮し、溶媒を溜
去した後、褐色の抽出物5.3gを得た。(3) 50 g of Zhuzi (commercially available as Zhizi) produced in Sichuan Province of China was immersed in 500 ml of 70% ethanol for 16 hours at room temperature (20 to 25 ° C.), and the supernatant was filtered. After collecting and concentrating at 45 ° C. under reduced pressure for 2 hours and distilling off the solvent, 5.3 g of a brown extract was obtained.
【0029】(4)日本薬局方外規格品加工ブシ末50
gを500mlの40%エタノールに、常温(20〜2
5℃)にて10時間浸し、上澄液をろ取し、45℃、減
圧下にて3時間濃縮し、溶媒を溜去した後、褐色の抽出
物6.1gを得た。(4) Japanese non-Pharmacopoeia standard product processed bush powder 50
g to 500 ml of 40% ethanol at room temperature (20-2
After dipping at 5 ° C. for 10 hours, the supernatant was collected by filtration, concentrated under reduced pressure at 45 ° C. for 3 hours, and the solvent was distilled off to obtain 6.1 g of a brown extract.
【0030】実施例1〜10、比較例1〜13(ヘアー
トニック) 下記に記載の成分組成において、製造例1で調製した附
子の抽出物と、分子量55,000のヒアルロン酸(以
下、HAと略記する)、分子量1,000,000のヒ
アルロン酸(以下、HALと略記する)、分子量4,8
00のヒアルロン酸ナトリウム(以下、HANと略記す
る)、分子量6,500のデルマタン硫酸(以下、DS
と略記する)、分子量7,000のデルマタン硫酸カリ
ウム(以下、DSKと略記する)、分子量5,000の
コンドロイチン4硫酸(以下、C4Sと略記する)、分
子量30,000のコンドロイチン4硫酸(以下、C4
SLと略記する)、分子量5,500のコンドロイチン
6硫酸(以下、C6Sと略記する)、分子量5,000
のコンドロイチン4硫酸L−リジン(以下、C4SLと
略記する)、分子量4,300のヘパリン(以下、He
pと略記する)、分子量5,400のヘパラン硫酸(以
下、HSと略記する)などの低分子量酸性ムコ多糖類等
とをそれぞれ表1、表2に記載の如く配合して各々のヘ
アートニックを調製し、前記の諸試験を実施した。Examples 1 to 10 and Comparative Examples 1 to 13 (Heartonic) In the composition of components shown below, the extract of the fusi prepared in Production Example 1 and hyaluronic acid having a molecular weight of 55,000 (hereinafter referred to as HA Abbreviated), hyaluronic acid having a molecular weight of 1,000,000 (hereinafter abbreviated as HAL), molecular weight 4,8
00 sodium hyaluronate (hereinafter abbreviated as HAN), dermatan sulfate having a molecular weight of 6,500 (hereinafter DS
), Potassium dermatan sulfate having a molecular weight of 7,000 (hereinafter abbreviated as DSK), chondroitin tetrasulfate having a molecular weight of 5,000 (hereinafter abbreviated as C4S), chondroitin tetrasulfate having a molecular weight of 30,000 (hereinafter, C4
SL), chondroitin 6-sulfate having a molecular weight of 5,500 (hereinafter abbreviated as C6S), molecular weight of 5,000
Chondroitin tetrasulfate L-lysine (hereinafter abbreviated as C4SL), heparin having a molecular weight of 4,300 (hereinafter, He
and a low molecular weight acidic mucopolysaccharide such as heparan sulfate having a molecular weight of 5,400 (hereinafter abbreviated as HS) are blended as shown in Table 1 and Table 2, respectively, to obtain respective hairnics. It was prepared and the above-mentioned tests were carried out.
【0031】 (1)組成 成 分 配合量(wt%) ─────────────────────────────────── エタノール 60.0 附子の抽出物、酸性ムコ多糖類等 表1、表2に記載 プロピレングリコール 1.0 香料 0.1 精製水 総量を100.0とする残量 ───────────────────────────────────(1) Composition Component content (wt%) ──────────────────────────────────── Ethanol 60.0 Bush extract, acidic mucopolysaccharides, etc. Described in Tables 1 and 2 Propylene glycol 1.0 Perfume 0.1 Purified water Remaining amount to make total amount 100.0 ────────── ───────────────────────────
【0032】(2)調製法 附子の抽出物及び香料をエタノール中に、酸性ムコ多糖
類等及びプロピレングリコールを精製水にそれぞれ溶解
し、各溶液を攪拌しながら均一に混合して各々のヘアー
トニックを調製した。(2) Preparation method The extract of Fuzi and the fragrance are dissolved in ethanol, the acidic mucopolysaccharides and propylene glycol are dissolved in purified water, and the respective solutions are uniformly mixed with stirring to obtain the respective hairnics. Was prepared.
【0033】(3)特性 各ヘアートニックの諸試験を実施した結果は、表1、表
2に示す如く、本発明の低分子量酸性ムコ多糖類を単独
配合である比較例1〜7、附子の抽出物単独配合である
比較例8〜11、あるいは高分子量酸性ムコ多糖類と附
子の抽出物との併用である比較例12,13は毛成長促
進効果が低く、また養毛、ふけ防止効果が認められなか
った。本発明の低分子量酸性ムコ多糖類と附子の抽出物
とを同時に配合した実施例1〜10の本発明の養毛料
は、マウスおよびヒトにおいて高い毛成長促進効果を示
し、実用試験の結果も良好な結果を示した。尚、実施例
1〜10はヒト皮膚での諸試験において皮膚刺激は生じ
なかった。(3) Characteristics As shown in Tables 1 and 2, the results obtained by conducting various tests of each Heartonic show the results of Comparative Examples 1 to 7 in which the low molecular weight acidic mucopolysaccharides of the present invention were blended alone, Comparative Examples 8 to 11 in which the extract alone is blended, or Comparative Examples 12 and 13 in which the high molecular weight acidic mucopolysaccharide and the extract of Fuzi are used in combination have a low hair growth promoting effect, and also have hair-raising and dandruff preventing effects. I was not able to admit. The hair nourishing agents of the present invention of Examples 1 to 10 in which the low molecular weight acidic mucopolysaccharide of the present invention and the extract of aconidium are mixed at the same time show a high hair growth promoting effect in mice and humans, and the results of practical tests are also good. It showed a good result. In Examples 1 to 10, skin irritation did not occur in various tests on human skin.
【0034】[0034]
【表1】 [Table 1]
【0035】[0035]
【表2】 [Table 2]
【0036】[0036]
【発明の効果】以上記載の如く、本発明が、顕著な毛成
長促進効果を示し、育毛効果、脱毛予防、およびふけ防
止効果に優れる養毛料を提供することは明らかである。EFFECTS OF THE INVENTION As described above, it is apparent that the present invention provides a hair nourishing agent which exhibits a remarkable hair growth promoting effect and is excellent in hair growth effect, hair loss prevention and dandruff prevention effect.
Claims (1)
の群より選択された少なくとも一種と附子の抽出物とを
配合してなる養毛料。1. A hair nourishing agent comprising at least one selected from the group of low-molecular-weight acidic mucopolysaccharides and salts thereof, and an extract of Fuzi.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP04089807A JP3113056B2 (en) | 1992-03-13 | 1992-03-13 | Hair restoration |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP04089807A JP3113056B2 (en) | 1992-03-13 | 1992-03-13 | Hair restoration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH05255045A true JPH05255045A (en) | 1993-10-05 |
| JP3113056B2 JP3113056B2 (en) | 2000-11-27 |
Family
ID=13980998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP04089807A Expired - Fee Related JP3113056B2 (en) | 1992-03-13 | 1992-03-13 | Hair restoration |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3113056B2 (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006101030A1 (en) * | 2005-03-22 | 2006-09-28 | Q.P. Corporation | Low molecular weight hyaluronic acid and/or salt thereof, method for producing same, and cosmetic preparation and food composition containing same |
| JP2008297549A (en) * | 2007-06-04 | 2008-12-11 | Taiwan Hopax Chemicals Manufacturing Co Ltd | Composition and synthesis of metal-polysaccharide conjugates |
| WO2011070948A1 (en) * | 2009-12-08 | 2011-06-16 | キユーピー株式会社 | Method for manufacturing purified hyaluronic acids |
| US8367818B2 (en) | 2006-02-24 | 2013-02-05 | Q.P. Corporation | Low molecular weight hyaluronic acid and/or salt thereof, and cosmetic preparation, pharmaceutical composition, and food composition each using same |
| JP2014516337A (en) * | 2011-01-31 | 2014-07-10 | ルコラス エム・ディー リミテッド | Cosmetic use |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101132114B1 (en) * | 2009-09-15 | 2012-04-05 | 일동제약주식회사 | Method of molecular weight control of hyaluronic acid |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK191889D0 (en) | 1989-04-20 | 1989-04-20 | Bukh Meditec | COSMETIC AGENT |
-
1992
- 1992-03-13 JP JP04089807A patent/JP3113056B2/en not_active Expired - Fee Related
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006101030A1 (en) * | 2005-03-22 | 2006-09-28 | Q.P. Corporation | Low molecular weight hyaluronic acid and/or salt thereof, method for producing same, and cosmetic preparation and food composition containing same |
| JP2006265287A (en) * | 2005-03-22 | 2006-10-05 | Q P Corp | Low molecular weight hyaluronic acid and / or salt thereof, process for producing the same, and cosmetics and food compositions containing the same |
| EP1865002A4 (en) * | 2005-03-22 | 2011-03-30 | Q P Corp | HYALURONIC ACID WITH LOW MOLECULAR WEIGHT AND / OR SALT THEREOF, PROCESS FOR PRODUCING THEM AND COSMETIC PREPARATION AND FOOD COMPOSITION CONTAINING SAME |
| US8933054B2 (en) | 2005-03-22 | 2015-01-13 | Q.P. Corporation | Low molecular weight hyaluronic acid and/or salt thereof, method for producing same, and cosmetic preparation and food composition containing same |
| US8367818B2 (en) | 2006-02-24 | 2013-02-05 | Q.P. Corporation | Low molecular weight hyaluronic acid and/or salt thereof, and cosmetic preparation, pharmaceutical composition, and food composition each using same |
| JP2008297549A (en) * | 2007-06-04 | 2008-12-11 | Taiwan Hopax Chemicals Manufacturing Co Ltd | Composition and synthesis of metal-polysaccharide conjugates |
| WO2011070948A1 (en) * | 2009-12-08 | 2011-06-16 | キユーピー株式会社 | Method for manufacturing purified hyaluronic acids |
| CN102648214A (en) * | 2009-12-08 | 2012-08-22 | 丘比株式会社 | Method for producing purified hyaluronic acid |
| US8829180B2 (en) | 2009-12-08 | 2014-09-09 | Kewpie Corporation | Method of purifying a low molecular weight hyaluronic acid or cationized hyaluronic acid via precipitation from aqueous solution by addition of alcohol or acetone followed by ph adjustment |
| KR101450983B1 (en) * | 2009-12-08 | 2014-10-15 | 큐피가부시키가이샤 | Method for manufacturing purified hyaluronic acids |
| JP2014516337A (en) * | 2011-01-31 | 2014-07-10 | ルコラス エム・ディー リミテッド | Cosmetic use |
| JP2017039759A (en) * | 2011-01-31 | 2017-02-23 | ルコラス エム・ディー リミテッドLUCOLAS−M.D.Ltd | Skin cosmetics |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3113056B2 (en) | 2000-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001518909A (en) | Use of at least one Irvingia gabonensis extract in cosmetics and / or pharmaceuticals | |
| JPH05255045A (en) | Hair grower | |
| JP3080767B2 (en) | Hair restoration | |
| JP4738682B2 (en) | Hair loss promoter | |
| JP3014212B2 (en) | Hair restoration | |
| JP2002332240A (en) | Hair grower composition | |
| JP3309914B2 (en) | Hair restoration | |
| JP3309915B2 (en) | Hair restoration | |
| JP3309916B2 (en) | Hair restoration | |
| JP3014211B2 (en) | Hair restoration | |
| JPH05170625A (en) | Hair tonic | |
| JPH03167113A (en) | Hair regenerating agent | |
| JP2005289999A (en) | Cosmetic composition comprising jujube extract and walnut extract | |
| JP3382149B2 (en) | External preparation for head | |
| JPH069349A (en) | Hair growing cosmetic | |
| JP3020727B2 (en) | Hair restoration | |
| JPH06135821A (en) | Hair tonic | |
| JP4577596B2 (en) | Hair restorer or hair growth agent and method of use thereof | |
| JP3159412B2 (en) | Skin cosmetics | |
| JP3524282B2 (en) | Hair growth promoter for hair growth | |
| JP3309917B2 (en) | Hair restoration | |
| JP2886611B2 (en) | Hair growth agent | |
| JPH05255048A (en) | Hair nourishing agent | |
| JP2519184B2 (en) | Hair nourishing cosmetics | |
| JPH05255047A (en) | Hair nourishing agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R371 | Transfer withdrawn |
Free format text: JAPANESE INTERMEDIATE CODE: R371 |
|
| S531 | Written request for registration of change of domicile |
Free format text: JAPANESE INTERMEDIATE CODE: R313531 |
|
| S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090922 Year of fee payment: 9 |
|
| LAPS | Cancellation because of no payment of annual fees |